ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0952

Single Cell RNA-seq of Scleroderma-associated Interstitial Lung Disease Lung Explants Reveals an Active, Cytotoxic Natural Killer Cell Population

Cristina Padilla, Eleanor Valenzi, Tracy Tabib, Banafsheh Nazari, Patrizia Fuschiotti and Robert Lafyatis, University of Pittsburgh, Pittsburgh, PA

Meeting: ACR Convergence 2024

Keywords: innate immunity, interstitial lung disease, Natural Killer Cells, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Scleroderma-associated interstitial lung disease (SSc-ILD) is the leading cause of death among SSc patients. Loss of alveolar epithelial cells (AEC) and bronchial cell hyperplasia, i.e., bronchiolization, are principal pathological features of the disease. While inflammation is known to be another primary disease feature, little is known about the potential role of lung lymphoid populations and particularly, natural killer (NK) cells on bronchiolization. What is known about NK cells in SSc comes from peripheral blood and bronchoalveolar lavage fluid and has not provided a consistent vision of their role in SSc. Using single cell RNA-sequencing (scRNA-seq), we have identified an activated, cytotoxic NK cell population in SSc lung tissue.

Methods: Lung tissues from 13 SSc-ILD and 6 healthy control (HC) lungs collected were processed and analyzed by 3’ 10X single cell RNA chemistry. Samples were normalized and batch-corrected before unsupervised UMAP clustering and subclustered further into specific lymphoid subpopulations. Differentially expressed genes were derived to identify lymphoid subclusters. Connectome, a program that analyzes ligand-receptor interactions within and between cell types in lung tissue, was utilized. Immunohistochemistry stains for CD56 and granzyme B (GZMB) in lung tissues were completed.

Results: 16 lymphocyte clusters in both SSc-ILD and HC, including three populations of NK cells, several populations of T cells, a proliferating population of lymphoid cells, and a cluster of interferon-activated T cells were identified.  We observed striking shifts in lymphoid cell populations in SSc-ILD lungs. SSc-ILD lungs showed a shift in CD56dim CD16+ NK cells toward an activated phenotype with strong upregulation of GZMB, CD226, interferon-gamma (IFN-γ), and its associated genes. Amphiregulin (AREG), a growth factor ligand, that binds epidermal growth factor receptor (EGFR), was shown for the first time to be highly upregulated in the SSc-ILD NK cells, demonstrating high-yield interaction with EGFR on basal and goblet cells via Connectome. Higher proportions of CD8+ T cells and regulatory T cells were also observed in SSc-ILD lungs.

Conclusion: SSc-ILD lungs are infiltrated by active, cytotoxic CD56dim CD16+ NK cells, showing increased expression of IFN-γ, GZMB, and AREG. These activated NK cells might kill AEC, contributing to the observed loss of these cells. The highly upregulated expression of AREG suggests that these cells might also contribute to bronchial epithelial cell hyperplasia as well as fibroblast activation via the AREG-EGFR pathway. Ongoing studies will clarify the pathological role of these cells in the bronchiolization and formation of honeycomb cysts in SSc-ILD. 

Supporting image 1

UMAP of lymphoid cell populations in lung explant (top) and separated by SSc-ILD and control (below

Supporting image 2

Single cell Connectomics cell-to-cell interaction by cell-types in the lung. Amphiregulin (AREG) from NK cells (pink) has likely high yield interaction with EGFR on bronchial epithelial cells, suggesting a role in lung tissue repair and remodeling in SSc-ILD.


Disclosures: C. Padilla: None; E. Valenzi: None; T. Tabib: None; B. Nazari: None; P. Fuschiotti: None; R. Lafyatis: None.

To cite this abstract in AMA style:

Padilla C, Valenzi E, Tabib T, Nazari B, Fuschiotti P, Lafyatis R. Single Cell RNA-seq of Scleroderma-associated Interstitial Lung Disease Lung Explants Reveals an Active, Cytotoxic Natural Killer Cell Population [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/single-cell-rna-seq-of-scleroderma-associated-interstitial-lung-disease-lung-explants-reveals-an-active-cytotoxic-natural-killer-cell-population/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-rna-seq-of-scleroderma-associated-interstitial-lung-disease-lung-explants-reveals-an-active-cytotoxic-natural-killer-cell-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology